Forbion Capital Fund III Cooperatief U.A. 13D and 13G filings for Replimune Group, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | Replimune Group, Inc. REPL | Forbion Capital Fund III Cooperatief U.A. | 4,219,340 6.100% | -895,781 (-17.51%) | Filing |
| 2024-11-14 07:00 am Sale | 2024-09-30 | 13G | Replimune Group, Inc. REPL | Forbion Capital Fund III Cooperatief U.A. | 5,115,121 7.500% | -76,500 (-1.47%) | Filing |
| 2024-02-14 07:21 am Purchase | 2023-12-31 | 13G | Replimune Group, Inc. REPL | Forbion Capital Fund III Cooperatief U.A. | 5,191,621 8.700% | 76,500 (+1.50%) | Filing |
| 2021-02-16 06:36 am Unchanged | 2020-12-31 | 13G | Replimune Group, Inc. REPL | Forbion Capital Fund III Cooperatief U.A. | 5,115,121 11.130% | 0 (Unchanged) | Filing |